Arabic Arabic English English French French German German
dark

Public Meeting: Patient-Focused Drug Development for Neuropathic Pain (Part 1 of 3)

On June 10, 2016, FDA hosted a public meeting on Patient-Focused Drug Development for Neuropathic Pain Associated with Peripheral Neuropathy. FDA was interested in obtaining patient perspectives on the impact of neuropathic pain associated with peripheral neuropathy on daily life and patient views on treatment approaches. For more information, visit the meeting webpage: https://go.usa.gov/xHrgH

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Canada-wide ban on menthol cigarettes leads to significant increases in quitting among smokers

Next Post

Al-Qassim: 60,000+ Patients Served by Physiotherapy & Rehabilitation Centers Last Year

Related Posts
Total
0
Share